What if the country with fewer psychiatric hospitals and less access to antipsychotic medication actually produced better recovery outcomes for schizophrenia? That was precisely the counterintuitive finding that emerged from a series of landmark WHO-led cross-cultural studies – and India was at the heart of this discovery. Alongside these transcultural investigations, researchers working within India’s own primary healthcare system were uncovering something equally important: a quiet epidemic of mental illness that general practitioners were almost entirely missing. Together, these two streams of research – one international, one deeply local – transformed how Indian mental health is understood, measured, and debated.
Table of Contents
- The WHO transcultural studies: India on the world stage
- The International Pilot Study of Schizophrenia (IPSS)
- Determinants of Outcome of Severe Mental Disorders (DOSMeD)
- What the Indian data really showed
- Clinical epidemiology in Indian primary care: the hidden burden
- ICMR’s role in building India’s mental health data
- Psychiatric morbidity in general health settings
- Why morbidity goes undetected: structural and social barriers
- ICMR’s push toward integrated care
- What these two research traditions tell us together
The WHO transcultural studies: India on the world stage
Before the 1960s, there was little reliable cross-national data on how schizophrenia presented and progressed across different cultures. That changed with a series of ambitious, multi-country studies coordinated by the World Health Organization, in which Indian research centres played a defining role.
The International Pilot Study of Schizophrenia (IPSS)
The IPSS was launched in 1965 with the primary goal of determining whether a rigorous follow-up study on schizophrenia could be conducted across vastly different cultural settings. It enrolled 1,202 patients across nine countries – three developing nations (Colombia, India, and Nigeria) and six developed ones (Denmark, Taiwan, the United Kingdom, the United States, the Soviet Union, and Czechoslovakia). Patient outcomes were assessed using three indicators: the percentage of time spent with psychotic symptoms, the type of remission after each episode, and the degree of social impairment – scored on a scale from one (best) to seven (worst).
Indian psychiatry was placed on the world map through the involvement of research centres in Agra and Chandigarh in both the IPSS and the subsequent DOSMeD study. The results from the five-year follow-up were striking. India and Nigeria had the highest percentage of patients with the best outcomes (66%) and the lowest percentage with worst outcomes (10%). This directly challenged the then-dominant Western psychiatric view that schizophrenia was an inevitably deteriorating condition.
It is worth noting that the major limitation of the IPSS was that its sample was not an epidemiological one – it drew only from patients already in psychiatric facilities, which may have skewed results toward more treatment-responsive cases.
Determinants of Outcome of Severe Mental Disorders (DOSMeD)
To address these sampling concerns, the WHO launched the DOSMeD study in the late 1970s. The DOSMeD study actively sought out patients not already in psychiatric facilities, examining schizophrenia incidence, prevalence, and outcomes across 12 centres in 10 countries, with 1,379 patients enrolled. Indian centres in both Chandigarh (urban and rural samples) and Agra were included, allowing for within-country comparisons as well.
The study found that complete clinical remission was significantly more common in developing country settings – recorded at 37% – compared to just 15.5% in developed countries. Patients in developing nations also spent significantly longer periods in unimpaired social functioning, even though only 16% of them were on continuous antipsychotic medication, against 61% in developed countries.
The DOSMeD findings prompted researchers to speculate on the reasons for this advantage, with particular focus on the role of family structures and socio-centric societies in India, which were seen as providing stronger support and placing fewer demands on the patient. One concrete measure of this was Expressed Emotion (EE) – a gauge of critical or hostile family attitudes. The DOSMeD reported that only 23% of households in Chandigarh were rated as high in Expressed Emotion, compared to 54% in Denmark. Urban Indian families showed higher EE than rural ones, and a lower proportion of high-EE relatives in Chandigarh was associated with better patient outcomes compared to a London sample.
What the Indian data really showed
Researchers have suggested that disorganised rural labour markets in developing countries may provide more flexible work opportunities – such as agricultural labour – for people with disabilities, aiding social integration and reducing stigma. Additionally, practices like yoga, widely observed in developing countries, have been found to reduce both positive and negative symptoms of schizophrenia.
However, neither IPSS nor DOSMeD was without methodological problems. Both studies experienced high attrition rates in developing countries, and it was generally the worst-performing patients who dropped out – a bias that may have made outcomes look more positive than they were. The WHO’s follow-up, the International Study of Schizophrenia (ISoS), conducted 15 to 25 years after the original studies, found that only half of the patients from developing countries who had shown the best outcomes in earlier studies maintained those outcomes over the long term. A subsequent review of 58 schizophrenia studies by psychiatrist Parmanand Kulhara in 2009 found that after 15 years, a larger proportion of patients in developing countries still showed better outcomes – but to a lesser extent than earlier data had suggested.
Despite these nuances, both the IPSS and DOSMeD together demonstrated that schizophrenia not only existed across the world, but had measurably better outcomes in developing countries like India. This changed how the world perceived schizophrenia and shifted psychiatry’s global perspective toward the influence of social and cultural determinants.
Clinical epidemiology in Indian primary care: the hidden burden
While the WHO studies were examining how Indians fared with severe mental disorders, a parallel body of research – much of it coordinated by the Indian Council of Medical Research (ICMR) – was turning attention to a different and troubling question: how much psychiatric illness was going undetected in everyday medical settings?
ICMR’s role in building India’s mental health data
The ICMR is the main body in India for the formulation, coordination, and promotion of biomedical research, and mental health has been one of its thrust research areas. The Council supported multi-centre studies across institutions including NIMHANS in Bengaluru, AIIMS in Delhi, and PGIMER in Chandigarh, covering both community prevalence surveys and clinically focused investigations in healthcare settings.
Across decades of ICMR-led and ICMR-supported research, a consistent pattern emerged. Despite wide variation in study designs, available data from Indian studies suggests that roughly 20% of the adult population is affected by one or another psychiatric disorder. These rates are broadly comparable to global figures – but they are not being identified or treated at scale.
Psychiatric morbidity in general health settings
The specific focus on primary care settings produced some of the most clinically significant data. People in India rarely approach a psychiatrist first; they go to a general practitioner or a primary health centre, presenting with headaches, fatigue, chest discomfort, or vague physical symptoms. The psychiatric illness underlying these presentations is frequently overlooked.
Studies using structured diagnostic tools such as the PRIME-MD Patient Health Questionnaire (PHQ) found that psychiatric morbidity is high in general medical outpatient settings in India, and in many cases it is either missed or misdiagnosed by physicians. Research at a mobile health clinic in South Delhi found that total estimated psychiatric morbidity was 25.4%, with depression as the most common disorder at 15.7%, followed by generalised anxiety at 11.1% and phobic disorders at 10.1%. Suicidal ideation was reported by 10.6% of patients.
A broader picture of the gap was captured in research across five Indian primary care settings, where all five standard screening questionnaires tested – including the GHQ and SRQ – showed moderate to high ability to detect common mental disorders, indicating that the tools exist to catch these cases. The bottleneck is not measurement; it is integration into routine care.
Why morbidity goes undetected: structural and social barriers
Healthcare providers at primary health centres have highlighted several barriers to detecting psychiatric illness. These include difficulty diagnosing psychiatric disorders due to overlapping symptoms and the absence of definitive diagnostic tests, patients’ reluctance to disclose mental illness out of fear of stigma, resistance to accepting a psychiatric label, and communication barriers. In short, even when patients do present to a general clinic, the conditions for proper psychiatric screening are rarely in place.
The burden this creates is substantial. An estimated one-third of patients with any chronic medical condition – including diabetes, hypertension, cancer, and heart disease – also have a co-morbid diagnosable psychiatric disorder, which typically goes undiagnosed and untreated. Similarly, about one-third of patients attending outpatient departments of primary health centres or general hospitals suffer from diagnosable psychiatric disorders such as somatoform disorders, depression, anxiety, and sleep disorders.
The treatment gap is stark. In India, the treatment gap for common mental disorders exceeds 80%. This means the overwhelming majority of people with diagnosable conditions are receiving no care at all – not because their illness is invisible in principle, but because the healthcare system is not structured to see it.
ICMR’s push toward integrated care
Recognising this, the ICMR has increasingly advocated for integrating mental health care into primary and general healthcare services. The ICMR-MINDS (Multistate Implementation Research study on Integration of Mental and Substance use Disorders with Non-Communicable Diseases) initiative, for example, was designed to embed psychiatric screening and management into existing NCD frameworks, targeting at least 70% coverage of screening and linkage to care across participating states. The rationale is clear: non-communicable diseases are already being managed by non-specialist healthcare workers at the primary care level, and since mental illness is highly co-morbid with other NCDs, integration is both logical and potentially cost-effective.
Researchers have argued that mental healthcare priorities in India must shift from a narrow focus on psychotic disorders to a broader attention on common mental disorders – and from psychiatric hospitals to primary health centres. This is not merely an administrative recommendation; it reflects what decades of clinical epidemiological research have shown about where the real burden lies.
What these two research traditions tell us together
The WHO transcultural studies and India’s clinical epidemiological work may seem like separate conversations, but they point to the same underlying truth: social context shapes mental health in profound ways. The IPSS and DOSMeD showed that family cohesion, community inclusion, and cultural attitudes can improve recovery from even severe disorders like schizophrenia. The ICMR-led primary care research showed that when those social and structural supports are absent – or when healthcare systems fail to detect illness – the burden falls silently on individuals, families, and communities.
Both streams of evidence argue for a mental healthcare model that is embedded in community life, sensitive to culture, and accessible at the first point of contact. Mental health services in India are still not adequately integrated into primary healthcare systems , but the research foundation for doing so has now been built over more than five decades.
What do you think? Given that India’s social structures – like close family networks – were linked to better schizophrenia recovery in the WHO studies, what might happen to those protective factors as urbanisation accelerates and family structures change? And if roughly one in five adults carries a psychiatric disorder that goes largely undetected in primary care, what does that suggest about the design of routine health check-ups?
Leave a Reply